Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(3-Mercaptopropanoyl)-D-alanine is a synthetic small molecule derivative of the amino acid D-alanine, in which the terminal nitrogen atom is acylated with a 3-mercaptopropanoyl group. It has been catalogued as an experimental compound and does not have any approved medical indications or known clinical use. Its precise mechanism of action and pharmacological properties are not described in available databases. The compound's structure features both an amino acid backbone and a free thiol group, which may suggest potential for biochemical reactivity or as a building block in peptide synthesis or chemical biology research[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-(3-mercaptopropanoyl)-D-alanine.